Breast cancer is characterized by dysregulation in multiple signaling pathways, including Wnt/β-catenin, NF-KB, P13K/AKT, p38, JNK, and ERK, all of which play roles in migration, EMT, metastasis, and apoptosis activation. This evidence concerns the gene MAPK8 and breast carcinoma.